# Oliver W. Press

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/oliver-w-press/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,384 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 84 |
| i10-index | 292 |
| OpenAlex ID | https://openalex.org/A5023180146 |
| ORCID iD | https://orcid.org/0000-0002-3147-8037 |
| Works | 572 |

## Researcher papers

- [Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study](https://scholariq.org/papers/safety-and-activity-of-the-anti-cd79b-antibody-drug-conjugate-polatuzumab/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.